Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation
Cancer · 15.06.2023 · 129 (12) · 1856-1865
DOI: 10.1002/cncr.34728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 09.03.2023. Verfasst von Daniel Nguyen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Disseminated Intravascular Coagulation, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Acute myeloid leukemia (AML) with rearrangement of lysine methyltransferase 2a gene ( KMT2Ar ) is characterized by chemotherapy resistance and high rates of relapse. However, additional causes of treatment failure or early mortality have not been well‐defined in this entity.
Methods
In a retrospective analysis, causes and rates of early mortality following induction treatment were compared between a cohort of adults with KMT2Ar AML ( N = 172) and an age‐matched cohort of patients with normal karyotype AML ( N = 522).
Results
The 60‐day mortality in patients with KMT2Ar AML was 15% compared with 7% with normal karyotype ( p = .04). We found a significantly higher occurrence of major bleeding events ( p = .005) and total bleeding events ( p = .001) in KMT2Ar AML compared with diploid AML. Among evaluable patients with KMT2Ar AML, 93% exhibited overt disseminated intravascular coagulopathy compared with 54% of patients with a normal karyotype before death ( p = .03). In a multivariate analysis, KMT2Ar and a monocytic phenotypic were the only independent predictors of any bleeding event in patients who died within 60 days (odds ratio, 3.5; 95% CI, 1.4–10.4; p = .03; odds ratio, 3.2; 95% CI, 1–1‐9.4; p = .04, respectively).
Conclusion
In conclusion, early recognition and aggressive management of disseminated intravascular coagulopathy and coagulopathy are important considerations that could mitigate the risk of death during induction treatment in KMT2Ar AML. Plain Language Summary Acute myeloid leukemia (AML) with rearrangement of KMT2A is characterized by chemotherapy resistance and high rates of relapse. However, additional causes of treatment failure or early mortality have not been well‐defined in this entity. In this article, that KMT2A ‐rearranged AML is demonstrably associated with higher early mortality and an increased risk of bleeding and coagulopathy, specifically, disseminated intravascular coagulation, compared with normal karyotype AML. These findings emphasize the importance of monitoring and mitigating coagulopathy in KMT2A ‐rearranged leukemia similar to what is done in acute promyelocytic leukemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Daniel Nguyen, Nicholas J Short, Jing Ning, Naval G Daver, Courtney D DiNardo, Elias J Jabbour, Tapan M Kadia, Guillermo Garcia-Manero, Koji Sasaki, Ghayas C Issa
Förderung
- NCI NIH HHS
Zitieren
APA
Nguyen, D., Kantarjian, H. M., Short, N. J., Qiao, W., Ning, J., Cuglievan, B., Daver, N. G., DiNardo, C. D., Jabbour, E. J., Kadia, T. M., Borthakur, G., Garcia-Manero, G., Konopleva, M. Y., Andreeff, M., Ravandi-Kashani, F., Sasaki, K., & Issa, G. C. (2023). Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer, 129(12), 1856-1865. https://doi.org/10.1002/cncr.34728
Vancouver
Nguyen D, Kantarjian HM, Short NJ, Qiao W, Ning J, Cuglievan B, et al. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer. 2023;129(12):1856-1865. doi:10.1002/cncr.34728
BibTeX
@article{Nguyen2023,
author = {Nguyen, Daniel and Kantarjian, Hagop M and Short, Nicholas J and Qiao, Wei and Ning, Jing and Cuglievan, Branko and Daver, Naval G and DiNardo, Courtney D and Jabbour, Elias J and Kadia, Tapan M and Borthakur, Gautam and Garcia-Manero, Guillermo and Konopleva, Marina Y and Andreeff, Michael and Ravandi-Kashani, Farhad and Sasaki, Koji and Issa, Ghayas C},
title = {Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation},
journal = {Cancer},
year = {2023},
volume = {129},
number = {12},
pages = {1856--1865},
doi = {10.1002/cncr.34728}
}
EUVIMED